Daniel B Soland Idera Pharmaceuticals, Inc. (IDRA) insider trading activity

IDRA Quotes by TradingView

Daniel B Soland is CHIEF OPERATING OFFICER of IDERA PHARMACEUTICALS, INC.. Currently has a direct ownership of 78,843 shares of IDRA, which is worth approximately $237,317. The most recent transaction as insider was on Jun 18, 2021, when has been sold 50,000 shares (Common Stock) at a price of $1.19 per share, resulting in proceeds of $59,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.8K
0% 3M change
0% 12M change
Total Value Held $237,317

DANIEL B SOLAND Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2021
BUY
Open market or private purchase
$59,500 $1.19 p/Share
50,000 Added 38.81%
78,843 Common Stock
Mar 05 2021
BUY
Open market or private purchase
$39,000 $3.9 p/Share
10,000 Added 25.74%
28,843 Common Stock

Also insider at

KALV
KalVista Pharmaceuticals, Inc. Healthcare
Director
DBVT
DBV Technologies S.A. Healthcare
Director
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
DBS

Daniel B Soland

CHIEF OPERATING OFFICER
Exton, PA

Track Institutional and Insider Activities on IDRA

Follow IDERA PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDRA shares.

Notify only if

Insider Trading

Get notified when an Idera Pharmaceuticals, Inc. insider buys or sells IDRA shares.

Notify only if

News

Receive news related to IDERA PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IDRA